Physician profile
Samuel Robert Brittingham
NPI 1770069353
$508.36
in general payments reported to CMS, 2019-2025
10 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.84 · 2022: $40.73 · 2023: $20.41 · 2024: $213 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $188.89 | 2021-2024 | Vasoview Hemopro 2 |
| Ethicon US, LLC | $79.39 | 2025 | Dermabond Prineo, Evarrest, Vistaseal |
| Davol INC. | $40.73 | 2022 | |
| Abbott Laboratories | $39.13 | 2024 | 2nd Gen Centrimag Primary Console |
| C. R. Bard, INC. & Subsidiaries | $33.32 | 2024 | Arista Ah Flexitip |
| Lsi Solutions INC | $32.42 | 2025 | Cor-Knot |
| Astrazeneca Pharmaceuticals LP | $26.53 | 2025 | Imfinzi |
| Atricure, INC. | $24.11 | 2021 | |
| Angiodynamics, INC. | $23.43 | 2024 | Angiovac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.41 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Brittingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.